CDC just released in MMWR a report of the first case of a Verona integron-encoded metallo-beta-lactamase (VIM) carbapenemase in an Enterobacteriaceae in the United States. The patient was initially hospitalized in Greece and then transferred to a US hospital. CDC was notified in July and, fortunately, the screening of the 22 patients whose U.S. hospital stays overlapped with this patient were all negative. I would write more, but a nice post by Alex Kallen from the CDC puts this in the proper context.
Sept 24 MMWR article
Alex Kallen CDC post
Subscribe to:
Post Comments (Atom)
OSHA! OSHA! OSHA!
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati...
-
In many parts of the country, as rates of COVID-19 are declining and vaccination coverage is increasing (albeit with substantial variati... -
This is a guest post by Jorge Salinas, MD, Hospital Epidemiologist at the University of Iowa Hospitals & Clinics. There is virtually no...
-
I’m surprised that we can’t stop arguing about the modes of SARS-CoV-2 transmission, despite the fact that most experts (including our frie...
No comments:
Post a Comment
Thanks for submitting your comment to the Controversies blog. To reduce spam, all comments will be reviewed by the blog moderator prior to publishing. However, all legitimate comments will be published, whether they agree with or oppose the content of the post.